Your price never goes up if your dose increases, so you can safely progress through dosing adjustments recommended by your provider without worrying about unexpected costs
Microvascular dysfunction contributes to disease progression in AD
Comprehensive monitoring should include assessment of therapeutic response and screening for potential adverse effects, particularly signs of malignancy given the angiogenic effects
Only two trials directly compared tirzepatide with semaglutide, with one of these also including a placebo arm [6, 7]
Electrolytes, fiber, and specific vitamins and minerals that may be under-consumed during periods of reduced food intake deserve particular attention
Appetite changes Some individuals experience reduced appetite, which can contribute to weight loss. Headaches and dizziness These symptoms may occur, particularly during the initial stages of therapy. Injection site reactions Redness, swelling, or discomfort at the injection site can happen, but is usually mild. Pancreatitis There have been reports linking GLP-1 receptor agonists to pancreatitis, an inflammation of the pancreas
